Astellas’ prostate cancer drug for metastasis-free survival gets nod
HQ Team November 18, 2023: The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of
HQ Team November 18, 2023: The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of
HQ Team November 18, 2023: A plan to create a safe zone at Gaza’s Al-Mawasi is a “recipe for disaster” and the WHO
HQ Team November 17, 2023: Levofloxacin, an antibiotic, has emerged as a potent weapon against drug-resistant tuberculosis, offering a cost-effective solution with profound
HQ Team November 17, 2023: The number of countries battling measles outbreaks has increased to 37 in 2022 from 22 in 2021, marking
HQ team November 17, 2023: A recent study suggests that delaying the clamping of the umbilical cord for premature babies may decrease the
HQ Team November 16, 2023: One in four older people experience social isolation, and one in six adolescents is socially isolated and lonely,
HQ Team November 16, 2023: The USFDA has approved a first test for chlamydia and gonorrhea that will allow people to collect samples
HQ Team November 15, 2023: Type 2 diabetic patients, especially African Americans and people with low income, are at a 47% increased risk
HQ Team November 14, 2023: Lowering sodium intake can reduce blood pressure regardless of whether one is on medication, a study reveals. Researchers
HQ Team November 14, 2023: At least 101 health workers, have died in Gaza, in attacks on hospitals and healthcare facilities since the